Top

Journal of Gastrointestinal Cancer

Published in:

01-03-2018 | Review Article

Staging, Treatment, and Future Approaches of Gallbladder Carcinoma

Authors: Sanjeev Kumar Shukla, Govind Singh, K. S. Shahi, Bhuvan, Prabhat Pant

Published in: Journal of Gastrointestinal Cancer | Issue 1/2018

Abstract

Background

Gallbladder cancer is the most common malignant cancer of the bile ducts and third most common gastrointestinal malignant in the world for public health. Its relatively low incidence and confused symptoms result in advanced disease at the time of presentation, contributing to poor prognosis and reduced survival associated with this disease. The main function of the gallbladder is to store excreted bile acids from the liver in preparation for a meal. Its main risk factor is prolonged exposure to biliary calculations, although bacterial infections and other inflammatory conditions are associated. Chronic inflammatory bowel conditions are associated with gallbladder cancer. T stage translates to identifying residual disease at reoperation for incidental gallbladder cancer and residual disease negatively affects survival.

Conclusion

It is the most common cancer of gallbladder, gallbladder cancer remains a rare disease. Gallbladder cancer is a rare disease that can be accidentally diagnosed after cholecystectomy or accidentally, often with more advanced disease. The prognosis is generally extremely poor and improvements in surgical resection of this approach have to be re-evaluated, while the role of chemotherapy and radiotherapy remains controversial.

Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000;95(3):784–7. https://doi.org/10.1111/j.1572-0241.2000.01860.x.CrossRefPubMed

Larsson SC, Kansson NH, Wolk A. Healthy dietary patterns and incidence of biliary tract and gallbladder cancer in a prospective study of women and men. Eur J Cancer. 2017;70:42–7. https://doi.org/10.1016/j.ejca.2016.10.012.CrossRefPubMed

Agarwal AK, Javed A, Kalayarasan R, Sakhuja P. Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study. HPB (Oxford). 2015;17(6):536–41. https://doi.org/10.1111/hpb.12406.CrossRef

Destoll M. Rationis mendendi. In: Haak et Socios A et J Honkoop, editor. Nosocomio practico vendobonensi, Part I. Lugduni Batavorum; 1788

DeRegato JA, Spjut HJ. Digestive tract/accessory organo gallbladder. In: Ackerman LV, JA DR, editors. Cancer—diagnosis, treatment and prognosis. 5th ed. St Louis: CV Mosby; 1977. p. 599–604.

Medina E. Las enfermedades digestivas en Chile, panorama epidemiologico. Revista Medica De Chile. 1988;116(3):282–8.PubMed

Moertel CG. The gallbladder. In: Holland JF, Frei III E, editors. Cancer medicine. 2nd ed. Philadelphia: Lea Ferbiger; 1982. 1782–1785.

Shen HX, Song HW, Xu XJ, Jiao ZY, Ti ZY, Li ZY, et al. Clinical epidemiological survey of gallbladder carcinoma in northwestern China. 2009-2013: 2379 cases in 17 centers. Chronic Dis Trans Med. 2017;3(1):60–6. https://doi.org/10.1016/j.cdtm.2017.01.003.CrossRef

Izarzugaza MI, Fernandez L, Forman D, Sierra MS. Burden of gallbladder cancer in Central and South America. Cancer Epidemiol. 2016;44:82–9.CrossRef

10.

Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211–7. https://doi.org/10.3748/wjg.v21.i43.12211.CrossRefPubMedPubMedCentral

11.

Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146–5.CrossRefPubMed

12.

Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA. Carcinoma of the gallbladder: does radical resection improve outcome. Arch Surg. 1990;125(2):237–41. https://doi.org/10.1001/archsurg.1990.01410140115019.CrossRefPubMed

13.

Gourgiotis S, Oikonomou C, Kollia P, Falidas E, Villias C. Persistent coughing as the first symptom of primary mucinous appendiceal adenocarcinoma. J Clin Med Res. 2015;7(8):649–52. https://doi.org/10.14740/jocmr2192w.CrossRefPubMedPubMedCentral

14.

Sobin LH, Wittekind C. Digestive system: gallbladder. In: TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 84–6.

15.

Qadan M, Kingham TP. Technical aspects of gallbladder cancer surgery. Surg Clin North Am. 2016;96(2):229–45. https://doi.org/10.1016/j.suc.2015.12.007.CrossRefPubMedPubMedCentral

16.

Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder: staging, treatment and prognosis. Cancer. 1976;37(1):141–8. https://doi.org/10.1002/1097-0142(197601)37:1<141::AID-CNCR2820370121>3.0.CO;2-Y.CrossRefPubMed

17.

Albores-Saavedra J, Henson DE, Sobin LH. The WHO histological classification of tumours of the gallbladder and extra hepatic bile duct a commentary on the second edition. Cancer. 1992;70(2):410–4. https://doi.org/10.1002/1097-0142(19920715)70:2<410::AID-CNCR2820700207>3.0.CO;2-R.CrossRefPubMed

18.

Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterol. 1999;117(3):632–9. https://doi.org/10.1016/S0016-5085(99)70456-7.CrossRef

19.

Venneman NG, VanErpecum KJ. Pathogenesis of gallstones. Gastroenterol Clin N Am. 2010;39(2):171–83. https://doi.org/10.1016/j.gtc.2010.02.010.CrossRef

20.

Carriaga M, Henson DE. Liver, gallbladder, extra hepatic bile ducts and pancreas. Cancer. 1995;75(S1):171–90. https://doi.org/10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2.CrossRefPubMed

21.

Pilgrim CH, Groeschl RT, Christians KK, Gamblin TC. Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB (Oxford). 2013;15(11):839–44. https://doi.org/10.1111/hpb.12046.CrossRef

22.

Sharma V, Chauhan VS, Nath G, Kumar A, Shukla VK. Role of bacteria in gallbladder carcinoma. Hepato-Gastroenterology. 2007;54(78):1622–5.PubMed

23.

Rai R, Sharma KL, Misra S, Kumar A, Mittal B. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene. 2013;530(2):172–7. https://doi.org/10.1016/j.gene.2013.08.058.CrossRefPubMed

24.

Maharaj R, Cave C, Sarran K, Bascombe N, Dan D, Greaves W, et al. A case report of the clear cell variant of gallbladder carcinoma. Int J Surg Case Rep. 2017;32:36–9. https://doi.org/10.1016/j.ijscr.2017.01.020.CrossRefPubMedPubMedCentral

25.

Sampliner RE, Bennett PH, Comers LJ, Rose FA, Burch TA. Gallbladder disease in Pima Indians demonstration of high prevalence and early onset by cholecystography. N Engl J Med. 1970;283(25):1358–64. https://doi.org/10.1056/NEJM197012172832502.CrossRefPubMed

26.

Cetta F. The role of bacteria in pigment gallstones disease. Ann Surg. 1991;231:315–26.CrossRef

27.

Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 45 million US male veterans. Cancer. 2011;117(6):1163–71. https://doi.org/10.1002/cncr.25524.CrossRefPubMed

28.

Koshiol J, Lam TK, Gridley G, Check D, Brown LM, Landgren O. Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin’s lymphoma in veterans from the United States. J Clin Oncol. 2011;29(4):378–85. https://doi.org/10.1200/JCO.2010.30.1515.CrossRefPubMed

29.

Castro FA, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K, et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin Gastroenterol Hepatol. 2014;12(6):1038–45. https://doi.org/10.1016/j.cgh.2013.11.007.CrossRefPubMed

30.

Shukla VK, Shukla PK, Pandey M, Rao BR, Salil KR. Lipid peroxidation product in bile from patients with carcinoma of the gallbladder: a preliminary study. J Surg Oncol. 1994;56(4):258–62. https://doi.org/10.1002/jso.2930560415.CrossRefPubMed

31.

Pandey M, Shukla VK. Fatty acids, biliary bile acids, lipid peroxidation products and gallbladder carcinogenesis. Eur J Cancer Prev. 2000;9(3):165–71. https://doi.org/10.1097/00008469-200006000-00003.CrossRefPubMed

32.

Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med. 2004;46(2):147–53. https://doi.org/10.1097/01.jom.0000111601.85534.12.CrossRefPubMed

33.

Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349–64. https://doi.org/10.3322/canjclin.51.6.349.CrossRefPubMed

34.

Sumiyoshi K, Nagai E, Chijiiwa K, Nakayama F. Pathology of carcinoma of the gallbladder. World J Surg. 1991;15(3):315–21. https://doi.org/10.1007/BF01658722.CrossRefPubMed

35.

Kim YT, Kim J, Jang YH, Lee WJ, Ryu JK, Park YK, et al. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett. 2001;169(1):59–68. https://doi.org/10.1016/S0304-3835(01)00562-6.CrossRefPubMed

36.

Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995;55(12):2511–5.PubMed

37.

Lee DK, Tarr PI, Haigh WG, Lee SP, Bacterial DNA. In mixed cholesterol gallstones. Am J Gastroenterol. 1999;94(12):3502–6. https://doi.org/10.1111/j.1572-0241.1999.01614.x.CrossRefPubMed

38.

Vassella E, Langsch S, Dettmer MS, Schlup C, Neuenschwander M, Frattini M, et al. Molecular profiling of lung adenosquamous carcinoma: hybrid orgenuine type. Oncotarget. 2015;6(27):23905–16. https://doi.org/10.18632/oncotarget.4163.CrossRefPubMedPubMedCentral

39.

Lin LL, Picus J, Drebin JA, Linehan DC, Solis J, Strasberg SM, et al. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Am J Clin Oncol. 2005;28(3):234–41. https://doi.org/10.1097/01.coc.0000156920.11091.12.CrossRefPubMed

40.

Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg. 2003;7(6):766–72. https://doi.org/10.1016/S1091-255X(03)00113-6.CrossRefPubMed

41.

Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27(3):260–5. https://doi.org/10.1007/s00268-002-6702-0.CrossRefPubMed

42.

Prior IA, Lewis PD, Mattos CA. Comprehensive survey of Ras mutations in cancer. Cancer Res. 2012;72(10):2457–67. https://doi.org/10.1158/0008-5472.CAN-11-2612.CrossRefPubMedPubMedCentral

43.

Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012;5(2):41–7.PubMedPubMedCentral

44.

Sherr CT, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2(2):103–12. https://doi.org/10.1016/S1535-6108(02)00102-2.CrossRefPubMed

45.

Doval D, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid A, et al. Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung. Onco Targets Ther. 2015;8:117–23. https://doi.org/10.2147/OTT.S74820.PubMedPubMedCentral

46.

Xuan YH, Choi YL, Shin YK, Kook MC, Chae SW, Park SM, et al. An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions. Histol Histopathol. 2005;20(1):59–66. https://doi.org/10.14670/HH-20.59.PubMed

47.

Maurya SK, Tewari M, Mishra RR, Shukla HS. Genetic aberrations in gallbladder cancer. Surg Oncol. 2012;21(1):37–43. https://doi.org/10.1016/j.suronc.2010.09.003.CrossRefPubMed

48.

Moy AP, Shahid M, Ferrone CR, Borger DR, Zhu AX, Ting D, et al. Microsatellite instability in gallbladder carcinoma. Virchows Arch. 2015;466(4):393–402. https://doi.org/10.1007/s00428-015-1720-0.CrossRefPubMed

Title: Staging, Treatment, and Future Approaches of Gallbladder Carcinoma
Authors: Sanjeev Kumar Shukla
Govind Singh
K. S. Shahi
Bhuvan
Prabhat Pant
Publication date: 01-03-2018
Publisher: Springer US
Published in: Journal of Gastrointestinal Cancer / Issue 1/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-017-0036-5

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Staging, Treatment, and Future Approaches of Gallbladder Carcinoma

Abstract

Background

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review

Nine-Year Follow-up in a Child with Antenatally Diagnosed Hepatoblastoma

Primary Desmoid-Type Fibromatosis of the Mesentery: Report of an Unusual Tumor Localization

Pancreatic Cancer Management and Treatment Landscape Awareness of Gastroenterologists: Results from US Physician Surveys Conducted in 2013 and 2015

Decreased MicroRNA miR-181c Expression Associated with Gastric Cancer

Is Watchful Waiting an Option in Margin-Positive Solid Pseudopapillary Neoplasms of the Pancreas?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page